nitroglycerin has been researched along with pioglitazone in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Gerhard-Herman, MD; O'connor, ME; Raji, A; Simonson, DC; Williams, JS | 1 |
Harano, Y; Suzuki, M; Takamisawa, I; Yoshimasa, Y | 1 |
Akasaka, T; Goto, M; Ikejima, H; Imanishi, T; Kuroi, A; Mochizuki, S; Muragaki, Y; Tsujioka, H; Yoshida, K | 1 |
1 review(s) available for nitroglycerin and pioglitazone
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
3 other study(ies) available for nitroglycerin and pioglitazone
Article | Year |
---|---|
Effect of pioglitazone on insulin sensitivity, vascular function and cardiovascular inflammatory markers in insulin-resistant non-diabetic Asian Indians.
Topics: Adipose Tissue; Administration, Sublingual; Adult; Aged; Biomarkers; Blood Glucose; Brachial Artery; Cardiovascular Diseases; Cross-Sectional Studies; Drug Administration Schedule; Endothelium, Vascular; Female; Glucose Clamp Technique; Humans; Hyperemia; Hypoglycemic Agents; India; Insulin; Insulin Resistance; Lipids; Male; Middle Aged; Nitroglycerin; Pioglitazone; Risk Factors; Thiazolidinediones; United States; Vasodilation; Vasodilator Agents | 2006 |
Association between insulin resistance and endothelial dysfunction in type 2 diabetes and the effects of pioglitazone.
Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Endothelium, Vascular; Female; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Male; Nitroglycerin; Pioglitazone; Thiazolidinediones; Vasodilation | 2007 |
Effect of pioglitazone on nitroglycerin-induced impairment of nitric oxide bioavailability by a catheter-type nitric oxide sensor.
Topics: Acetylcholine; Animals; Biopterins; Calibration; Catheterization; Dose-Response Relationship, Drug; Drug Interactions; Drug Monitoring; Hypoglycemic Agents; Male; Models, Animal; Nitric Oxide; Nitroglycerin; Pioglitazone; PPAR gamma; Rabbits; Thiazolidinediones; Tyrosine; Vasodilator Agents | 2008 |